Zika Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

The global market for Zika Vaccines was estimated to be worth US$ 14680 million in 2023 and is forecast to a readjusted size of US$ 18530 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Zika Vaccines Market Size

M= millions and B=billions

Report Scope
This report aims to provide a comprehensive presentation of the global market for Zika Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Zika Vaccines by region & country, by Type, and by Application.

The Zika Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zika Vaccines.

Market Segmentation

• Report Metric

• Details

• Report Title

• Zika Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Forecasted Market Size in 2030

• US$ 18530 million

• CAGR(2024-2030)

• 2.9%

• Market Size Available for Years

• 2019-2030

• Global Zika Vaccines Companies Covered

• Bharat Biotech, Inovio Pharmaceuticals, Cerus Corporation, Sanofi, NewLink Genetics, Immunovaccine, GlaxoSmithKline

• Global Zika Vaccines Market, by Region

• North America (U.S., Canada, Mexico)

  Europe (Germany, France, UK, Italy, etc.)

  Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

  South America (Brazil, etc.)

  Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

• Global Zika Vaccines Market, Segment by Type

• Therapeutic Vaccines

  Preventive Vaccines

• Global Zika Vaccines Market, Segment by Application

• Hospitals

  Clinics

  Ambulatory Surgery Centers

  Others

• Forecast Units

• USD million in value

• Report Coverage

• Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Zika Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Zika Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Zika Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Zika Vaccines Product Introduction
    1.2 Global Zika Vaccines Market Size Forecast
        1.2.1 Global Zika Vaccines Sales Value (2019-2030)
        1.2.2 Global Zika Vaccines Sales Volume (2019-2030)
        1.2.3 Global Zika Vaccines Sales Price (2019-2030)
    1.3 Zika Vaccines Market Trends & Drivers
        1.3.1 Zika Vaccines Industry Trends
        1.3.2 Zika Vaccines Market Drivers & Opportunity
        1.3.3 Zika Vaccines Market Challenges
        1.3.4 Zika Vaccines Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Zika Vaccines Players Revenue Ranking (2023)
    2.2 Global Zika Vaccines Revenue by Company (2019-2024)
    2.3 Global Zika Vaccines Players Sales Volume Ranking (2023)
    2.4 Global Zika Vaccines Sales Volume by Company Players (2019-2024)
    2.5 Global Zika Vaccines Average Price by Company (2019-2024)
    2.6 Key Manufacturers Zika Vaccines Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Zika Vaccines Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Zika Vaccines
    2.9 Zika Vaccines Market Competitive Analysis
        2.9.1 Zika Vaccines Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Zika Vaccines Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zika Vaccines as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Therapeutic Vaccines
        3.1.2 Preventive Vaccines
    3.2 Global Zika Vaccines Sales Value by Type
        3.2.1 Global Zika Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Zika Vaccines Sales Value, by Type (2019-2030)
        3.2.3 Global Zika Vaccines Sales Value, by Type (%) (2019-2030)
    3.3 Global Zika Vaccines Sales Volume by Type
        3.3.1 Global Zika Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Zika Vaccines Sales Volume, by Type (2019-2030)
        3.3.3 Global Zika Vaccines Sales Volume, by Type (%) (2019-2030)
    3.4 Global Zika Vaccines Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Ambulatory Surgery Centers
        4.1.4 Others
    4.2 Global Zika Vaccines Sales Value by Application
        4.2.1 Global Zika Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Zika Vaccines Sales Value, by Application (2019-2030)
        4.2.3 Global Zika Vaccines Sales Value, by Application (%) (2019-2030)
    4.3 Global Zika Vaccines Sales Volume by Application
        4.3.1 Global Zika Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Zika Vaccines Sales Volume, by Application (2019-2030)
        4.3.3 Global Zika Vaccines Sales Volume, by Application (%) (2019-2030)
    4.4 Global Zika Vaccines Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Zika Vaccines Sales Value by Region
        5.1.1 Global Zika Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Zika Vaccines Sales Value by Region (2019-2024)
        5.1.3 Global Zika Vaccines Sales Value by Region (2025-2030)
        5.1.4 Global Zika Vaccines Sales Value by Region (%), (2019-2030)
    5.2 Global Zika Vaccines Sales Volume by Region
        5.2.1 Global Zika Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Zika Vaccines Sales Volume by Region (2019-2024)
        5.2.3 Global Zika Vaccines Sales Volume by Region (2025-2030)
        5.2.4 Global Zika Vaccines Sales Volume by Region (%), (2019-2030)
    5.3 Global Zika Vaccines Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Zika Vaccines Sales Value, 2019-2030
        5.4.2 North America Zika Vaccines Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Zika Vaccines Sales Value, 2019-2030
        5.5.2 Europe Zika Vaccines Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Zika Vaccines Sales Value, 2019-2030
        5.6.2 Asia Pacific Zika Vaccines Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Zika Vaccines Sales Value, 2019-2030
        5.7.2 South America Zika Vaccines Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Zika Vaccines Sales Value, 2019-2030
        5.8.2 Middle East & Africa Zika Vaccines Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Zika Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Zika Vaccines Sales Value
        6.2.1 Key Countries/Regions Zika Vaccines Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Zika Vaccines Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Zika Vaccines Sales Value, 2019-2030
        6.3.2 United States Zika Vaccines Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Zika Vaccines Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Zika Vaccines Sales Value, 2019-2030
        6.4.2 Europe Zika Vaccines Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Zika Vaccines Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Zika Vaccines Sales Value, 2019-2030
        6.5.2 China Zika Vaccines Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Zika Vaccines Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Zika Vaccines Sales Value, 2019-2030
        6.6.2 Japan Zika Vaccines Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Zika Vaccines Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Zika Vaccines Sales Value, 2019-2030
        6.7.2 South Korea Zika Vaccines Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Zika Vaccines Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Zika Vaccines Sales Value, 2019-2030
        6.8.2 Southeast Asia Zika Vaccines Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Zika Vaccines Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Zika Vaccines Sales Value, 2019-2030
        6.9.2 India Zika Vaccines Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Zika Vaccines Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bharat Biotech
        7.1.1 Bharat Biotech Company Information
        7.1.2 Bharat Biotech Introduction and Business Overview
        7.1.3 Bharat Biotech Zika Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Bharat Biotech Zika Vaccines Product Offerings
        7.1.5 Bharat Biotech Recent Development
    7.2 Inovio Pharmaceuticals
        7.2.1 Inovio Pharmaceuticals Company Information
        7.2.2 Inovio Pharmaceuticals Introduction and Business Overview
        7.2.3 Inovio Pharmaceuticals Zika Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Inovio Pharmaceuticals Zika Vaccines Product Offerings
        7.2.5 Inovio Pharmaceuticals Recent Development
    7.3 Cerus Corporation
        7.3.1 Cerus Corporation Company Information
        7.3.2 Cerus Corporation Introduction and Business Overview
        7.3.3 Cerus Corporation Zika Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Cerus Corporation Zika Vaccines Product Offerings
        7.3.5 Cerus Corporation Recent Development
    7.4 Sanofi
        7.4.1 Sanofi Company Information
        7.4.2 Sanofi Introduction and Business Overview
        7.4.3 Sanofi Zika Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Sanofi Zika Vaccines Product Offerings
        7.4.5 Sanofi Recent Development
    7.5 NewLink Genetics
        7.5.1 NewLink Genetics Company Information
        7.5.2 NewLink Genetics Introduction and Business Overview
        7.5.3 NewLink Genetics Zika Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 NewLink Genetics Zika Vaccines Product Offerings
        7.5.5 NewLink Genetics Recent Development
    7.6 Immunovaccine
        7.6.1 Immunovaccine Company Information
        7.6.2 Immunovaccine Introduction and Business Overview
        7.6.3 Immunovaccine Zika Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Immunovaccine Zika Vaccines Product Offerings
        7.6.5 Immunovaccine Recent Development
    7.7 GlaxoSmithKline
        7.7.1 GlaxoSmithKline Company Information
        7.7.2 GlaxoSmithKline Introduction and Business Overview
        7.7.3 GlaxoSmithKline Zika Vaccines Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 GlaxoSmithKline Zika Vaccines Product Offerings
        7.7.5 GlaxoSmithKline Recent Development

 8 Industry Chain Analysis
    8.1 Zika Vaccines Industrial Chain
    8.2 Zika Vaccines Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Zika Vaccines Sales Model
        8.5.2 Sales Channel
        8.5.3 Zika Vaccines Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Zika Vaccines Market Trends
    Table 2. Zika Vaccines Market Drivers & Opportunity
    Table 3. Zika Vaccines Market Challenges
    Table 4. Zika Vaccines Market Restraints
    Table 5. Global Zika Vaccines Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Zika Vaccines Revenue Market Share by Company (2019-2024)
    Table 7. Global Zika Vaccines Sales Volume by Company (2019-2024) & (K Doses)
    Table 8. Global Zika Vaccines Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Zika Vaccines Price by Company (2019-2024) & (USD/Dose)
    Table 10. Key Manufacturers Zika Vaccines Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Zika Vaccines Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Zika Vaccines
    Table 13. Global Zika Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zika Vaccines as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Zika Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Zika Vaccines Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Zika Vaccines Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Zika Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Zika Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Zika Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Doses)
    Table 22. Global Zika Vaccines Sales Volume by Type (2019-2024) & (K Doses)
    Table 23. Global Zika Vaccines Sales Volume by Type (2025-2030) & (K Doses)
    Table 24. Global Zika Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Zika Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Zika Vaccines Price by Type (2019-2024) & (USD/Dose)
    Table 27. Global Zika Vaccines Price by Type (2025-2030) & (USD/Dose)
    Table 28. Global Zika Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Zika Vaccines Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Zika Vaccines Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Zika Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Zika Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Zika Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Doses)
    Table 34. Global Zika Vaccines Sales Volume by Application (2019-2024) & (K Doses)
    Table 35. Global Zika Vaccines Sales Volume by Application (2025-2030) & (K Doses)
    Table 36. Global Zika Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Zika Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Zika Vaccines Price by Application (2019-2024) & (USD/Dose)
    Table 39. Global Zika Vaccines Price by Application (2025-2030) & (USD/Dose)
    Table 40. Global Zika Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Zika Vaccines Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Zika Vaccines Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Zika Vaccines Sales Value by Region (2019-2024) & (%)
    Table 44. Global Zika Vaccines Sales Value by Region (2025-2030) & (%)
    Table 45. Global Zika Vaccines Sales Volume by Region (K Doses): 2019 VS 2023 VS 2030
    Table 46. Global Zika Vaccines Sales Volume by Region (2019-2024) & (K Doses)
    Table 47. Global Zika Vaccines Sales Volume by Region (2025-2030) & (K Doses)
    Table 48. Global Zika Vaccines Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Zika Vaccines Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Zika Vaccines Average Price by Region (2019-2024) & (USD/Dose)
    Table 51. Global Zika Vaccines Average Price by Region (2025-2030) & (USD/Dose)
    Table 52. Key Countries/Regions Zika Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Zika Vaccines Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Zika Vaccines Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Zika Vaccines Sales Volume, (2019-2024) & (K Doses)
    Table 56. Key Countries/Regions Zika Vaccines Sales Volume, (2025-2030) & (K Doses)
    Table 57. Bharat Biotech Company Information
    Table 58. Bharat Biotech Introduction and Business Overview
    Table 59. Bharat Biotech Zika Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 60. Bharat Biotech Zika Vaccines Product Offerings
    Table 61. Bharat Biotech Recent Development
    Table 62. Inovio Pharmaceuticals Company Information
    Table 63. Inovio Pharmaceuticals Introduction and Business Overview
    Table 64. Inovio Pharmaceuticals Zika Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 65. Inovio Pharmaceuticals Zika Vaccines Product Offerings
    Table 66. Inovio Pharmaceuticals Recent Development
    Table 67. Cerus Corporation Company Information
    Table 68. Cerus Corporation Introduction and Business Overview
    Table 69. Cerus Corporation Zika Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 70. Cerus Corporation Zika Vaccines Product Offerings
    Table 71. Cerus Corporation Recent Development
    Table 72. Sanofi Company Information
    Table 73. Sanofi Introduction and Business Overview
    Table 74. Sanofi Zika Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 75. Sanofi Zika Vaccines Product Offerings
    Table 76. Sanofi Recent Development
    Table 77. NewLink Genetics Company Information
    Table 78. NewLink Genetics Introduction and Business Overview
    Table 79. NewLink Genetics Zika Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 80. NewLink Genetics Zika Vaccines Product Offerings
    Table 81. NewLink Genetics Recent Development
    Table 82. Immunovaccine Company Information
    Table 83. Immunovaccine Introduction and Business Overview
    Table 84. Immunovaccine Zika Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 85. Immunovaccine Zika Vaccines Product Offerings
    Table 86. Immunovaccine Recent Development
    Table 87. GlaxoSmithKline Company Information
    Table 88. GlaxoSmithKline Introduction and Business Overview
    Table 89. GlaxoSmithKline Zika Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 90. GlaxoSmithKline Zika Vaccines Product Offerings
    Table 91. GlaxoSmithKline Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Zika Vaccines Downstream Customers
    Table 95. Zika Vaccines Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Zika Vaccines Product Picture
    Figure 2. Global Zika Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Zika Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Zika Vaccines Sales Volume (2019-2030) & (K Doses)
    Figure 5. Global Zika Vaccines Sales Price (2019-2030) & (USD/Dose)
    Figure 6. Zika Vaccines Report Years Considered
    Figure 7. Global Zika Vaccines Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Zika Vaccines Players Sales Volume Ranking (2023) & (K Doses)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Zika Vaccines Revenue in 2023
    Figure 10. Zika Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Therapeutic Vaccines Picture
    Figure 12. Preventive Vaccines Picture
    Figure 13. Global Zika Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Zika Vaccines Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Zika Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)
    Figure 16. Global Zika Vaccines Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Zika Vaccines Price by Type (2019-2030) & (USD/Dose)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Ambulatory Surgery Centers
    Figure 21. Product Picture of Others
    Figure 22. Global Zika Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Zika Vaccines Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Zika Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)
    Figure 25. Global Zika Vaccines Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Zika Vaccines Price by Application (2019-2030) & (USD/Dose)
    Figure 27. North America Zika Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Zika Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Zika Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Zika Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Zika Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Zika Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Zika Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Zika Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Zika Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Zika Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Zika Vaccines Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Zika Vaccines Sales Volume (%), (2019-2030)
    Figure 39. United States Zika Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Zika Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Zika Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Zika Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Zika Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Zika Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Zika Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Zika Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Zika Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Zika Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Zika Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Zika Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Zika Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Zika Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Zika Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Zika Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Zika Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Zika Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Zika Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Zika Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Zika Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 60. Zika Vaccines Industrial Chain
    Figure 61. Zika Vaccines Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

The global market for Zika Vaccines was estimated to be worth US$ 14680 million in 2023 and is forecast to a readjusted size of US$ 18530 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Zika Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Zika Vaccines by region & country, by Type, and by Application.

The Zika Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zika Vaccines.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Zika Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Zika Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Zika Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.